BioMarin Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionWalleye Capital LLC
Latest Disclosed Ownership364,246 shares
Latest Disclosed Value $ 20,576,257
Walleye Capital LLC ownership in BMRN / BioMarin Pharmaceutical Inc.

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 364,246 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $20,576,257 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 222,467 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 63.73% during the quarter. The current value of the position is $20,678,245 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (BMRN) in the form of stock options. The firm currently holds call options representing 33,100 of underlying shares valued at $1,869,819 USD and put options representing 6,200 of underlying shares valued at $350,238 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BMRN / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 364,246 141,779 63.73 20,576 55.63 0.0856
2026-05-08 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 364,246 141,779 20,576 0.0855
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 222,467 150,655 209.79 13,221 239.96 0.0406
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 71,812 71,746 108,706.06 3,889 129,533.33 0.0146
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 66 -32,705 -99.80 4 -99.87 0.0000
2025-05-14 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,771 4,699 16.74 2,317 25.53 0.0105
2025-02-13 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 28,072 -127,370 -81.94 1,845 -83.11 0.0045
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 155,442 117,119 305.61 10,926 246.31 0.0227
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 38,323 3,639 10.49 3,155 4.16 0.0056
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,684 22,111 175.86 3,029 149.92 0.0054
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,573 7,572 151.41 1,212 174.21 0.0026
2023-11-21 2023-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 5,001 -43,638 -89.72 442 -89.52 0.0011
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,001 -43,638 442 0.0011
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 48,639 -88,633 -64.57 4,216 -68.41 0.0153
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 137,272 71,798 109.66 13,348 97.02 0.2000
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 65,474 -27,272 -29.41 6,776 -13.83 0.1236
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 92,746 52,496 130.42 7,862 135.67 0.1500
2022-08-19 2022-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 40,250 -75,399 -65.20 3,336 -62.59 0.0919
2022-08-08 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 40,250 -75,399 3,336 0.0919
2022-05-27 2022-03-31 13F/A-01 BIOMARIN PHARMACEUTICAL COM 09061G101 115,649 104,154 906.08 8,917 777.66 0.2383
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 115,649 104,154 8,917 0.1815
2022-05-27 2021-12-31 13F/A-01 BIOMARIN PHARMACEUTICAL COM 09061G101 11,495 11,495 1,016 0.0316
2022-03-03 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,495 11,495 1,016 0.0254
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -3,560 -100.00 0 -100.00
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,560 3,560 297 0.0101
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -822 -100.00 0 -100.00
2019-08-14 2019-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 822 822 73 0.0120
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 822 73 0.0120
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Call 33,100 -8.31 1,870 -12.87 n/a n/a n/a
2026-05-08 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 33,100 1,870 n/a n/a n/a
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 36,100 5,057.14 2,145 5,697.30 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 700 -96.37 38 -96.51 n/a n/a n/a
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 19,300 -35.45 1,061 -49.83 n/a n/a n/a
2025-05-14 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 29,900 -41.72 2,114 -37.32 n/a n/a n/a
2025-02-13 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 51,300 -24.89 3,372 -29.77 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 68,300 186.97 4,801 145.02 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 23,800 -10.53 1,959 -15.67 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 26,600 421.57 2,323 373.12 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 5,100 920.00 492 1,015.91 n/a n/a n/a
2023-11-21 2023-09-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 500 -58.33 44 -57.69 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 500 44 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 1,200 -94.83 104 -95.39 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 23,200 321.82 2,256 296.31 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 5,500 569 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 3,200 -84.83 271 -80.94 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 21,100 40.67 1,422 10.66 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 15,000 -16.20 1,285 -19.18 n/a n/a n/a
2019-08-14 2019-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Call 17,900 1,590 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 17,900 1,590 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Put 6,200 -24.39 350 -28.13 n/a n/a n/a
2026-05-08 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 6,200 350 n/a n/a n/a
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 8,200 148.48 487 173.60 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 3,300 -26.67 179 -27.94 n/a n/a n/a
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 4,500 -81.01 247 -85.25 n/a n/a n/a
2025-05-14 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 23,700 -5.95 1,675 1.15 n/a n/a n/a
2025-02-13 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 25,200 5.44 1,656 -1.37 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 23,900 16.02 1,680 -0.94 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 20,600 112.37 1,696 100.12 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 9,700 -58.37 847 -62.29 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 23,300 20.10 2,247 30.89 n/a n/a n/a
2023-11-21 2023-09-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 19,400 122.99 1,717 127.59 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 19,400 1,717 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 8,700 -55.15 754 -60.02 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 19,400 361.90 1,886 334.56 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 4,200 435 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 500 -96.77 42 -95.98 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 15,500 3,000.00 1,045 2,388.10 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Put 4,900 435 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 4,900 435 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.